New targets for cancer chemotherapy.

Arbuck, S G; Dancey, J; Pluda, J M; Grochow, L; Murgo, A J; Ivy, P; Wright, J; Blaylock, B; Via, L E; Sausville, E A

Arbuck, S G; Dancey, J; Pluda, J M; Grochow, L; Murgo, A J; Ivy, P; Wright, J; Blaylock, B; Via, L E; Sausville, E A.

Affiliation

Arbuck SG; Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, 6130 Executive Boulevard, Room 715, Rockville, MD 20852, USA.

Cancer Chemother Biol Response Modif ; 19: 237-88, 2001.

Article in En | MEDLINE | ID: mdl-11686017

Subject(s)

Antineoplastic Agents/therapeutic use; Cell Cycle Proteins/antagonists & inhibitors; Enzyme Inhibitors/therapeutic use; Neoplasms/drug therapy; Animals; Cell Cycle/drug effects; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Neoplasms/enzymology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cell Cycle Proteins / Enzyme Inhibitors / Neoplasms / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: Cancer Chemother Biol Response Modif Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: United States Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links